Article Details

Sacituzumab Govitecan Has Significant Benefits in Advanced Triple-Negative Breast Cancer

Retrieved on: 2021-06-04 18:45:00

Tags for this article:

Click the tags to see associated articles and topics

Sacituzumab Govitecan Has Significant Benefits in Advanced Triple-Negative Breast Cancer. View article details on hiswai:

Excerpt

ADCs are monoclonal antibodies conjugated to cytotoxic agents via a linker and have tumor specificity and potency that is not usually achievable with ...

Article found on: www.pharmacytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up